论文部分内容阅读
本文评价了去甲肾上腺素再摄入阻滞剂麦普替林和5-羟色胺(5-HI)再摄入阻滞剂氟西汀在卒中患者体疗中运动功能恢复的疗效。 52例均为经头颅CT证实的大脑中动脉区缺血性卒中后不能行走1～6个月的患者,随机分为3个治疗组:在体疗基础上分别加服安慰剂、麦普替林150 mg/d、氟西汀20 mg/d治疗3个月,出现持续或严重副作用时停药。神经功能损害程度用等级神经病学量表(HSS)评价,高分提示严重神经功能损害。抑郁症状发
This article reviews the efficacy of norepinephrine reuptake blockers, metoprenaline and 5-hydroxytryptamine (5-HI) reuptake blocker fluoxetine, in motor function recovery in stroke patients. Fifty-two patients were all patients who could not walk for 1 to 6 months after ischemic stroke in the middle cerebral artery area confirmed by skull CT. They were randomly divided into three treatment groups: placebo, Lin 150 mg / d, fluoxetine 20 mg / d treatment for 3 months, discontinuation of sustained or serious side effects. The severity of neurological impairment was assessed using the Grade Neurology Scale (HSS), which showed a high level of neurologic impairment. Depression symptoms hair